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Abstract  
The response of mesenchymal stem cells (MSCs) to a matrix largely depends on the composition as well 
as the extrinsic mechanical and morphological properties of the substrate to which they adhere to. 
Collagen-glycosaminoglycan (CG) scaffolds have been extensively used in a range of tissue engineering 
applications with great success. This is due in part to the presence of the glycosaminoglycans (GAGs) in 
complementing the biofunctionality of collagen. In this context, the overall goal of this study was to 
investigate the effect of two GAG types: chondroitin sulphate (CS) and hyaluronic acid (HyA) on the 
mechanical and morphological characteristics of collagen-based scaffolds and subsequently on the 
differentiation of rat MSCs in vitro. Morphological characterisation revealed that the incorporation of HyA 
resulted in a significant reduction in scaffold mean pore size (93.9 µm) relative to collagen-CS (CCS) 
scaffolds (136.2 µm). In addition, the collagen-HyA (CHyA) scaffolds exhibited greater levels of MSC 
infiltration in comparison to the CCS scaffolds. Moreover, these CHyA scaffolds showed significant 
acceleration of early stage gene expression of SOX-9 (approximately 60-fold higher, p<0.01) and 
collagen type II (approximately 35-fold higher, p<0.01) as well as cartilage matrix production (7-fold higher 
sGAG content) in comparison to CCS scaffolds by day 14. Combining their ability to stimulate MSC 
migration and chondrogenesis in vitro, these CHyA scaffolds show great potential as appropriate matrices 
for promoting cartilage tissue repair.  
 
Keywords: Chondrogenesis, scaffold, collagen, glycosaminoglycan, chondroitin sulphate, hyaluronic acid.  
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1. Introduction 
Degeneration of cartilage and bone leading to osteoarthritis (OA) within human joints remains one of the 
most common causes of disability in the adult population. Approximately 12% of adults aged over 25 
years in the United States of America were diagnosed with symptoms of OA in 2005 (Lawrence et al., 
2008). Articular cartilage is a highly specialised tissue which is organised into distinct layers. These 
include an overlying articular cartilaginous layer, an intermediate calcified cartilage layer and an 
underlying layer of subchondral bone. Superficial articular cartilage injury eventually causes permanent 
changes to the underlying bone tissue and subsequently results in OA, characterised by chronic regional 
pain and dysfunction (Dieppe and Lohmander, 2005). The response of cartilage to injury differs from that 
of other tissue types because of its inability to heal even the most minor defects. This has been mainly 
attributed to its avascular nature, limited mobility of chondrocytes and poor proliferative capacity of 
mature chondrocytes (Newman, 1998). In the hip and knee joints, severe OA generally leads to the 
requirement for arthroplasty or replacement of the joint with artificial prostheses (Culliford et al., 2010). 
Numerous problems exist with arthroplasty and patients are often faced with living with pain, reduced 
mobility and eventually revision arthroplasty. In recent years, the focus has moved to regenerating 
cartilage through surgical repair techniques such as osteochondral grafting (mosaicplasty), bone marrow 
stimulation techniques and autologous chondrocyte implantation (ACI). These approaches have shown 
promise by promoting synthesis of de novo tissue and restoring some joint function over a short term 
period. However, long term performance of de novo tissue is still a major challenge with none of these 
approaches encouraging total repair of tissue with physiologically similar hyaline-like cartilage and as a 
consequence, surface fibrillation and subsequent degeneration often occurs (Buckwalter, 1997, Gobbi et 
al., 2006, Gross et al., 2008). The potential of tissue engineering (TE) to promote defect healing has been 
recognised (Cascio and Sharma, 2008, Getgood et al., 2009), although the ideal scaffold-based tissue 
engineered solution has yet to be realised. 
 
A major challenge in cartilage TE is the design and fabrication of biomaterials that are instructive for 
specific cellular functions, thereby regulating cellular adhesion, proliferation and synthesis of cartilage 
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matrix in a controllable manner (Miot et al., 2005). Various natural materials are derived from components 
of the extracellular matrix (ECM), with polypeptides and polysaccharides being the most widely used due 
to their biodegradability and non-toxic degradation products. Collagen has received a lot of attention in TE 
owing to its abundance and its mechanical properties which exceed those of other natural materials 
(Aigner and Stove, 2003, Harley et al., 2007). Collagen possesses an abundance of functional groups 
along its structure allowing interaction with other molecules such as polysaccharides and protein-based 
growth factors (Getgood et al., 2009). The biofunctionality and regenerative capacity of collagen can be 
significantly improved by the addition of glycosaminoglycans (GAGs) (Tierney et al., 2009). Scaffolds 
fabricated from copolymers of collagen and GAGs have been successfully applied in vitro and in vivo for 
skin, tendon, nerve, conjunctiva and more recently for bone and cartilage repair applications (Yannas and 
Burke, 1980, Louie et al., 1997, Chamberlain et al., 1998, Pieper et al., 2000, Hsu et al., 2000, Farrell et 
al., 2006, Lyons et al., 2010a).  
 
Articular cartilage ECM is composed of water (approximately 60-80 wt%), collagen (approximately 20 
wt%, 90% of which is collagen type II) and GAGs (approximately 8 wt%). The GAG content is 
predominantly composed of chondroitin sulphate and keratan sulphate which are held together into 
aggregates by hyaluronic acid by means of specialised link proteins (Temenoff and Mikos, 2000). From a 
TE perspective, the interaction of GAGs with other ECM molecules and cells as well as their role in 
improving the response of collagen-based scaffolds for tissue regeneration, is of great interest. In 
particular, the addition of GAGs to collagen has the effect of altering the physical characteristics of 
collagen fibres, the morphology and subsequent cell response (Harley et al., 2007). Previous work in our 
laboratory has led to the development of novel collagen-GAG (CG) scaffolds optimised for orthopaedic 
applications which are fabricated using a freeze-drying technique that produces highly porous matrices 
with an interconnected pore structure (Haugh et al., 2009). These scaffolds have been shown to support 
mesenchymal stem cell (MSC) differentiation down an osteogenic lineage and to a lesser extent a 
chondrogenic lineage in vitro (Farrell et al., 2006). One of the main advantages of the GAGs within 
scaffolds is the potential for cells to interact with them through cell surface receptors, which may influence 
cell behaviour and direct MSC differentiation (Chung and Burdick, 2008). Studies previously carried out 
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on cartilage regeneration have shown that GAGs are fundamental for presenting motifs for cell 
attachment and migration. In addition, GAGs have also been attributed to activating pathways that govern 
proliferation and differentiation as well as assembly of the ECM (Pieper et al., 2000, Banu and Tsuchiya, 
2007, Wu et al., 2010, Correia et al., 2011). Specifically, chondroitin sulphate (CS) which is the main type 
of GAG in cartilage ECM has been shown to stimulate chondrogenesis in vitro and promotes cellular 
ingrowth and cartilaginous tissue formation in vivo (van Susante et al., 2001, Buma et al., 2003). 
However, another GAG type, hyaluronic acid (HyA) has been shown to contribute to the migration and 
proliferation of MSCs and chondrocytes via association with specific cell surface receptors such as CD44 
and RHAMM (Receptor for Hyaluronic Acid Mediated Migration) (Turley et al., 1993, Zhu et al., 2006, 
Toole, 2001). Moreover, the presence of HyA within scaffolds has been shown to create a chondro-
inductive environment in vitro and in vivo promoting synthesis of cartilage tissue (Wu et al., 2010, Correia 
et al., 2011, Nehrer et al., 2006, Welsch et al., 2010).  
 
In this study, we hypothesised that the presence of different GAGs within a CG scaffold would markedly 
alter MSC proliferation, differentiation and production of synthesised matrix. The aim was to elucidate the 
influence of two different GAG types (CS and HyA) incorporated within CG scaffolds on the mechanical 
and morphological properties and response of MSCs. Specifically, we investigated the effect of GAG type 
on the compressive modulus and mean pore size of scaffolds. We also examined how the presence of 
the two different GAG types affects the cross-linking mechanism after dehydrothermal (DHT) treatment. 
Subsequently, we investigated the ability of these GAG types to affect MSC proliferation and 
differentiation down a chondrogenic lineage (through chondrocyte-specific gene expression) and matrix 
production in vitro after 14 and 28 days. 
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2. Materials and methods 
2.1 Fabrication of Collagen-Glycosaminoglycan scaffolds 
CG scaffolds were fabricated using a freeze-drying method that has been previously described (O'Brien 
et al., 2004). CCS scaffolds were composed of collagen type I derived from bovine Achilles tendon 
(Collagen Matrix, USA) and CS derived from shark cartilage (Sigma-Aldrich, Arklow, Ireland). CHyA 
scaffolds were composed of collagen type I derived from bovine Achilles tendon (Collagen Matrix, USA) 
and HyA sodium salt derived from streptococcus equi (Sigma-Aldrich, Arklow, Ireland). Both CCS and 
CHyA suspensions were made by dissolving collagen and GAG in 0.5 M (pH 2.8) glacial acetic acid 
separately and blended at 15,000 rpm (IKAT18, IKA Works Inc, NC, USA). The blending process was 
carried out for 3.5 hours in a cooling system (WKL230, Lauda Brinkman, Westbury, CT, USA) at 4°C in 
order to prevent denaturation. The final concentrations of the suspensions were composed of 0.5% (w/v) 
collagen and 0.05% (w/v) CS or HyA. A GAG-free collagen suspension with a final concentration of 0.5% 
(w/v) collagen was also fabricated. Subsequently, the suspensions were freeze-dried (Virtis Genesis 
25EL, Biopharma, Winchester, UK) at a constant cooling rate of 1°C/min to a final temperature of -40°C. 
After freeze-drying, the scaffolds were cross-linked using DHT treatment under vacuum of 50 mTorr and a 
temperature of 105ºC in a vacuum oven (VacuCell, MMM, Germany) for a duration of 24 hours.  
 
2.2 Mechanical and morphological characterisation 
2.2.1 Effect of GAG type on mean scaffold pore size 
Pore size analysis was carried out using a histological technique previously described (O'Brien et al., 
2005). Scaffold samples were obtained from three fixed locations on each fabricated sheet of the 
scaffolds. These samples were cut using a metal punch with a diameter of 9.5 mm and embedded in JB-4 
glycolmethacrylate (Polysciences Europe, Eppelheim, Germany) and serially sectioned longitudinally and 
transversely on a microtome (Leica RM 2255, Leica, Germany) to give 10 µm thick sections. Histological 
sections were stained using toluidine blue (Sigma-Aldrich, Arklow, Ireland). Digital images were captured 
at 10x magnification using a microscope (Eclipse 90i, Nikon, Japan) and a digital camera (DS Ri1, Nikon, 
Japan).  Pore size analysis was carried out on MATLAB (MathWorks Inc, MA, USA) using a  pore 
topology analyser developed in conjunction with the Sigmedia Research Group in the Electrical 
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Engineering Department at Trinity College Dublin, Ireland (Haugh et al., 2009). The programme 
transformed the images into binary form and calculated the average pore radii based on best-fit elliptical 
lengths. 
  
2.2.2 Effect of GAG type on molecular interaction and cross-linking mechanism after dehydrothermal 
treatment 
Fourier Transform Infrared Spectroscopy (FTIR) microscopy was carried out using a BRUKER Tensor-27 
FTIR spectroscopy machine (Bruker Tensor 27, Bruker Optik, Ettlingen, Germany) utilizing the attenuated 
total reflectance technique and OPUS data collection software (Bruker Optik). Cylindrical samples (8 mm 
diameter) were used for the analysis and milled with potassium bromide which is transparent to infrared. 
The spectra were collected over a range of 400–4000 cm
-1
 to monitor differences in the biochemical 
compositions of scaffolds before and after cross-linking as well as the cross-linking mechanism involved. 
The spectra were obtained at a resolution of 4 cm
-1
 and the samples were scanned 32 times to increase 
the signal-to-noise ratio. Formation of cross-links through DHT treatment was monitored by analyzing the 
characteristic amide I and II band absorbance peaks at 1630 cm
-1 
and 1550 cm
-1 
respectively. The band 
at 1550 cm
-1
 is proportional to the amount of amine NH2, which is converted to amide NH during the 
formation of cross-links through condensation reactions. Additionally, absorbance between 970 cm
-1
 and 
1300 cm
-1
 was assessed to observe the presence of ester bonds which correspond to GAG content within 
the scaffold structure.  
 
2.2.3 Effect of GAG type on scaffold compressive modulus 
Uni-axial, unconfined compressive testing was carried out to determine the compressive elastic modulus. 
Samples were pre-hydrated in phosphate buffered saline (PBS, Sigma-Aldrich, Arklow, Ireland) for 1 hour 
prior to testing. A mechanical testing machine (Z050, Zwick-Roell, Germany) was fitted with a 5 N load 
cell and used in the procedure. The pre-hydrated samples were kept immersed in PBS throughout the 
tests. The tests were conducted at a strain rate of 10% per minute and each sample was tested three 
times. Stress was calculated from scaffold surface area and applied force, whilst strain was calculated 
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from displacement of the scaffolds in relation to the original thickness. The compressive modulus was 
defined based on the slope of a linear fit to the stress-strain curve over 2-5% strain. 
 
2.3 In vitro analysis 
2.3.1 Cell isolation  
MSCs were isolated from the bone marrow of three month old wistar rats (approximately 250-300 g) after 
ethical approval from an internal ethics committee. The femora and tibiae were dislocated and the bone 
marrow was flushed out and MSCs isolated on the basis of adherence to tissue culture plastic (Duffy et 
al., 2011). The cells were incubated with Dulbecco’s modified eagles medium (DMEM, Sigma-Aldrich, 
Arklow, Ireland) supplemented with 10% fetal bovine serum (Biosera, Ringmer, UK), 100 U/mL 
penicillin/streptomycin (Sigma-Aldrich, Arklow, Ireland), 2 mM glutamax (Gibco-Biosciences, Dun 
Laoghaire, Ireland), 1 mM L-glutamine (Sigma-Aldrich, Arklow, Ireland) and 1% non-essential amino acids 
(Gibco-Biosciences, Dun Laoghaire, Ireland). Once the cells reached a confluence of between 80-90%, 
they were passaged and re-plated onto T-175 (175 cm
2
 growth area) flasks. For the entirety of this study, 
cells were cultured onto scaffolds at passage number 3.  
 
2.3.2 Cell culture 
Cells were detached from culture flasks using trypsin ethylenediaminetetraacetic acid (EDTA, Sigma-
Aldrich, Arklow, Ireland). Subsequently, cells were counted and re-suspended at a cell density of 5X10
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cells per mL and a total volume of 100 µL per scaffold. Scaffolds of 9.5 mm in diameter and 4 mm in 
height were pre-hydrated in PBS for 15 minutes, and placed in 6 well-plates. The cell suspension was 
then added to the scaffolds, 50 µL on one side of each scaffold and incubated for 15 minutes in a 5% 
CO2, 37°C incubator to allow initial attachment. The seeded scaffolds were subsequently turned over and 
the procedure repeated. After the second incubation period, 5 mL of supplemented DMEM growth 
medium was added to each well and pre-cultured for 7 days (medium change on day 3). After 7 days, the 
growth medium was replaced with medium supplemented with chondrogenic factors. The chondrogenic 
factors included 20 ng/mL human TGF-β3 (Prospec, Rehovot, Israel), 50 µg/mL ascorbic acid (Sigma-
Aldrich, Arklow, Ireland), 40 µg/mL proline (Sigma-Aldrich, Arklow, Ireland), 100 nM dexamethasone 
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(Sigma-Aldrich, Arklow, Ireland), 1X ITS (Insulin, Transferrin, Selinium) (BD Biosciences, Oxford, UK), 
and 0.11 mg/mL sodium pyruvate (Sigma-Aldrich, Arklow, Ireland). The wells were subsequently 
incubated for a further 14 and 28 days with medium being changed at day 3 intervals. 
 
2.3.3 Effect of GAG type on cell density 
Cell-seeded and cell-free control scaffolds were washed in PBS before digesting in a solution prepared 
from papain enzyme solution containing 0.5 M EDTA, cysteine-HCL and 1 mg/ml papain enzyme (Carica 
papaya, Sigma-Aldrich, Arklow, Ireland). Cell number was quantified using a Hoechst dye 33258 assay 
which fluorescently labels double stranded DNA as previously described (Murphy et al., 2010). 
Measurements were taken from a fluorometric plate reader (Wallac 1420 Victor
2
 D, Perkin Elmer, MA, 
USA) at an emission of 460 nm and excitation of 355 nm, 1.0 s. The measurements were read against a 
standard curve to obtain the relative cell numbers per scaffold in terms of the DNA content.  
 
2.3.4 Histological analysis of scaffolds 
Samples were fixed in 10% formalin for 1 hour and using a histokinette tissue processor (Leica TP1050, 
Leica Microsystems, Wetzler, Germany), were dehydrated and paraffin wax embedded. Blocks of wax 
embedded samples were serially sectioned using a microtoming machine (Leica RM2255, Leica 
Microsystems, Wetzler, Germany) which sliced the samples at 10 µm thick sections and every 20th 
section was used to give a gap of 200 µm between sections. These sections were successively mounted 
on polysine-coated glass slides (Fisher-Scientific, Dublin, Ireland). The glass slides were then 
deparaffinised and hydrated before staining. Stains used in the histological analysis were haematoxylin 
which stains the DNA and RNA rich cell nuclei, eosin which stains the extracellular matrix, safranin-O 
which stains sulfated GAGs and fast green, a light counter stain for the sections. 
 
2.3.5 RNA extraction and gene expression analysis 
The total RNA was isolated using an RNeasy kit (Qiagen, Crawley, UK) as previously described (Duffy et 
al., 2011). 200 ng of total RNA was reverse transcribed to cDNA using a QuantiTect reverse transcription 
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kit (Qiagen) on an authorised thermal cycler (Mastercycler Personal, Eppendorf, UK). Real time 
polymerase chain reactions were run on 7500 real-time PCR System (Applied Biosystems, UK) using a 
QuantiTect SYBR Green PCR Kit (Qiagen, UK). The relative expression of mRNA was calculated by 
delta-delta Ct (ΔΔCt)
 
method, where delta Ct (ΔCt)
 
is the value obtained by subtracting the Ct value of a 
house-keeping gene GAPDH, from the Ct value of the target mRNA (collagen type I, collagen type II, 
collagen type X and SOX-9). These target genes were chosen since they are expressed in cells 
differentiating down a characteristic chondrogenic lineage.  
The amount of target mRNA relative to GAPDH was normalised to a calibrator sample to generate ΔΔCt. 
This was then converted to a fold increase in expression using the formula: Fold increase = 2
-(ΔΔCt)
 
(Dussault and Pouliot, 2006).  
 
2.3.6 Effect of GAG type on sulfated GAG production 
Scaffolds were digested in papain enzyme solution as described in the cell density assay. A solution of di-
methyl-methylene blue (DMMB) dye was prepared from 0.3% glycine, 0.25% sodium chloride, and 1.6% 
DMMB dye. A standard curve was generated from serial dilutions of chondroitin sulphate in Tris-EDTA 
(pH 8.0). Digested samples were diluted in Tris-EDTA buffer at a ratio of 1:10 digest to buffer. 180 µL per 
well of DMMB dye was subsequently added into a 96 well plate as well as 20 µL of the diluted digested 
samples. Readings were taken from a photometric plate reader (Wallac 1420 Victor
2
 D, Perkin Elmer, 
MA, USA) at 530 nm, 1.0 s. The background photometric reading of the scaffolds was accounted for by 
subtracting the reading of cell-free scaffolds from the average reading of each cell-seeded scaffold. 
 
2.3.7 Effect of synthesised matrix on the bulk compressive moduli of scaffolds 
During the incubation period, the compressive modulus of the seeded scaffolds was investigated to 
determine the effect of synthesised sGAG content on the overall bulk compressive modulus. Scaffolds 
were seeded with rMSCs in growth medium and pre-cultured for 7 days and subsequently transferred to 
chondrogenic supplemented medium for up to 28 days. At days 0, 14 and 28 uni-axial, unconfined 
compressive testing was carried out on samples immersed in PBS using a mechanical testing machine 
(Zwick-Roell, Germany) as mentioned previously. 
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2.3.8 Statistical analysis 
Differences among groups were assessed by two-way ANOVA with Tukey’s post hoc analysis to identify 
statistical differences among three or more treatments when p was less than 0.05. Comparisons between 
two treatments were assessed by student’s paired t-test to identify statistical differences when p was less 
than 0.05. A sample size of 3 per group was used throughout the study unless otherwise state. All results 
were reported as mean + standard deviation.  
 
3. Results 
3.1 Effect of GAG type on scaffold morphology   
Figure 1 shows representative SEM images of a CG scaffold demonstrating the pore interconnectivity. 
The addition of HyA significantly reduced the mean pore size of the collagen scaffolds (Table. 1). GAG-
free collagen scaffolds possessed a mean pore size of 103.1 µm. The addition of CS resulted in scaffolds 
with the largest mean pore size of 136.2 µm which was significantly larger (p<0.05) than the mean pore 
size of the GAG-free collagen scaffolds. However, the addition of HyA resulted in scaffolds which 
possessed approximately 10% smaller mean pore size (93.9 µm) than GAG-free collagen scaffolds. All 
three scaffold variants were found to be highly porous with porosities over 98% regardless of presence or 
absence of GAGs. 
 
3.2 Effect of GAG type on infrared absorption using Fourier transform infrared (FTIR) microscopy 
FTIR spectra were analysed on all scaffolds and it was evident that the presence of different GAG types 
did not affect the cross-linking mechanism after DHT treatment (Fig. 2). Absorption bands corresponding 
to cross-link bonds between collagen and GAG molecules were present on the absorption spectrum.  
Specifically, ester bands corresponding to bonds between carboxyl and hydroxyl groups of collagen and 
GAG were present on the spectra of CCS and CHyA scaffolds between 970 and 1300 cm
-1
. 
Intermolecular cross-links between the collagen molecules were also present on all three scaffold variants 
after DHT treatment between carboxyl and amino groups. In particular, amide II bands at 1550 cm
-1
 and 
amide I bands at 1630 cm
-1
 were present on all scaffold variants. 
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3.3 Effect of GAG type on scaffold compressive modulus 
The compressive moduli of the scaffold variants was measured in untreated and DHT treated scaffolds 
and the results demonstrated that the moduli of all three scaffold variants was significantly increased 
(p<0.05) after DHT treatment (Fig. 3). The moduli of all untreated scaffolds were between 0.2 and 0.25 
kPa and there was no significant difference between GAG-free collagen and CG scaffolds. After DHT 
treatment, the modulus of all scaffold variants significantly increased by approximately 2-fold (between 
0.45 kPa and 0.55 kPa). However, no significant difference between GAG-free collagen, CCS and CHyA 
scaffolds was found.  
 
3.4 Effect of GAG type on cell density 
DNA quantification was assessed to determine the increase in cell density (cells per scaffold) from the 
point of seeding and the results demonstrated that CG scaffolds had a higher cell density than GAG-free 
scaffolds at day 14 (Fig. 4). The presence of both CS and HyA significantly increased cell density by day 
14 (approximately 2-fold higher than GAG-free collagen scaffolds, p<0.05). However, by day 28, the cell 
density of GAG-free and CG scaffolds was comparable.  
 
3.5 Effect of GAG type on cellular infiltration and sulphated GAG distribution within scaffolds 
Histological analysis revealed that CHyA scaffolds displayed greater levels of cell migration towards the 
centre of scaffolds with a resulting homogeneous cellular distribution throughout the construct (Fig. 5). 
Consequently, there was greater distribution of sulphated GAG content on these CHyA scaffolds. GAG-
free collagen scaffolds on the other hand, showed poor migration of cells towards the centre of the 
scaffold since the majority of cells adhered to the periphery (Fig. 5A). Similarly, CCS scaffolds displayed 
an encapsulation of cells on the periphery limiting the migration of cells towards the centre of the scaffold 
(Fig. 5B). Additionally, dense staining for sulphated GAG content was observed to be predominant on the 
periphery of collagen and CCS scaffolds.  
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3.6 Effect of GAG type on gene expression 
Real-time RT-PCR analysis showed that overall, CHyA scaffolds resulted in significantly higher SOX-9 
and collagen type II expression than CCS or GAG-free scaffolds as early as 14 days post-seeding (Fig. 
6). It was evident that early stage markers of chondrogenesis appeared to be highly expressed much 
faster in the presence of HyA than in the presence of CS or GAG-free scaffolds. In particular, by day 14 
the level of collagen type I and SOX-9 were found to be expressed significantly higher in the presence of 
HyA (90-fold higher collagen type I and 200-fold higher SOX-9 expression, p<0.01) than GAG-free 
collagen scaffolds. Additionally, collagen type II expression was also found to be higher in the presence of 
HyA than GAG-free scaffolds (40-fold higher collagen type II expression, p<0.01). Comparing the CG 
scaffolds, it was evident that the presence of HyA resulted in significantly higher SOX-9 and collagen type 
II expression than in the presence of CS (p<0.01) by day 14.  
 
By day 28 however, SOX-9 and collagen type II gene expression were found to be significantly higher on 
CCS scaffolds than CHyA scaffolds (p<0.01). GAG-free scaffolds also showed significantly higher levels 
of SOX-9 expression than CHyA scaffolds by day 28 although expression of collagen type II still remained 
minimal. There was no evidence of significant differences in the expression of late stage marker collagen 
type X between the three scaffold variants by day 28.  
 
3.7 Effect of GAG type on sulfated GAG production 
The effect of GAG type on the quantity of sGAG synthesised on scaffolds demonstrated that the presence 
of HyA significantly accelerated sGAG production relative to CS or GAG-free scaffolds (Fig. 7). By 14 
days post-seeding, the level of sGAG per cell was significantly higher (p<0.05) in the presence of HyA (32 
µg/µg sGAG/DNA) than in the presence of CS (4 µg/µg) or absence of GAG (3 µg/µg sGAG/DNA). 
Between day 14 and 28 there was a significant increase in production of sGAG in CCS scaffolds (39 
µg/µg sGAG/DNA) and GAG-free collagen scaffolds (37 µg/µg sGAG/DNA). CHyA scaffolds had a total 
sGAG content of 41 µg/µg sGAG/DNA by 28 days. There was no significant difference in the quantity of 
sGAG between the 3 scaffold variants by day 28.  
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3.8 Effect of synthesised sulphated GAG matrix on the bulk compressive moduli of scaffolds 
The results showed that following culture, the modulus of all scaffold variants increased due to the newly 
laid down matrix when normalised to seeded scaffolds at day 0 (Fig. 8). GAG-free collagen scaffolds 
showed a significant increase in compressive modulus from 0.5 to 1.1 kPa from day 0 to day 28 (p<0.05). 
On the other hand, CCS scaffolds showed a significant increase in compressive modulus from 0.6 kPa to 
1.62 kPa from day 0 to day 28 (p<0.05). CHyA scaffolds showed a significant increase in compressive 
modulus from 0.6 kPa to 1.67 kPa from day 0 to day 28 (p<0.05). By day 28, CG scaffolds had a 
significantly higher (p<0.05) bulk compressive moduli than GAG-free collagen scaffolds (approximately 
0.4 kPa higher).   
 
 
4. Discussion  
The overall goal of this study was to investigate the effect of incorporation of two different GAG types CS 
and HyA on the mechanical and morphological characteristics of collagen scaffolds and subsequently the 
response of seeded rMSCs in vitro. The results demonstrated that although CHyA scaffolds possessed 
smaller mean pore sizes, these scaffolds were able to stimulate greater levels of rMSC infiltration in 
comparison to CCS scaffolds. Moreover, these CHyA scaffolds promoted significant up-regulation of early 
stage gene expression of SOX-9 (approximately 60-fold higher, p<0.01) and collagen type II (35-fold 
higher, p<0.01) in comparison to CCS scaffolds. Additionally, CHyA scaffolds promoted greater levels of 
cartilage matrix production (7-fold higher sGAG content, p<0.01) in comparison to CCS scaffolds at day 
14. Taken together, the ability of the different GAG types to elicit distinct MSC response in terms of 
cellular migration and cartilage-specific matrix production in vitro demonstrates that the composition of 
scaffolds plays a major role in the type and quality of cartilage tissue synthesised. 
 
Morphologically, the addition of HyA resulted in significant reduction of scaffold mean pore size (93 µm) 
relative to CS (136 µm). Although we produced both scaffold types using identical freeze-drying 
parameters, analysis of the experimental temperature profiles of both CCS and CHyA suspensions (data 
not shown) demonstrated that the CHyA suspension cooled to the final temperature -40°C much quicker 
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than CCS suspensions. The freezing characteristics of CHyA scaffolds, which determine the pore size of 
the fabricated scaffolds, were thus different to CCS scaffolds. The composition of a colloidal suspension 
clearly affects the freezing dynamics of the material during the lyophilisation process used in this study to 
produce the collagen-based scaffolds. The thermal conductivity of these suspensions is governed by 
composition and can increase or decrease the rate of freezing for a given set of freezing parameters. 
Consequently, a higher thermal coefficient results in a higher rate of freezing, which in turn affects the 
nucleation rate of ice crystals. Faster freezing produces smaller ice crystals and smaller mean pore sizes 
after sublimation. Based on the temperature profiles recorded, the thermal conductivity of CHyA 
suspension appeared to be higher than CCS suspensions, resulting in a smaller average pore size in the 
CHyA scaffolds. 
 
GAG type did not affect the overall compressive modulus of CG scaffolds. However, as expected, DHT 
cross-linking treatment led to significant increases in the compressive moduli of all scaffold variants (2-
fold increase relative to uncross-linked scaffolds) (Fig. 3). Using cross-linking treatment, the mechanical 
properties of collagen scaffolds can be improved by stabilising the interaction between collagen 
molecules. Additionally, CG scaffolds can be improved by stabilising the interaction between collagen and 
GAG molecules which dissociate at near neutral pH. From a TE perspective, improving the mechanical 
properties of scaffolds is beneficial especially for their performance in vivo. The mechanical properties of 
a substrate or scaffold have been shown to affect the fate of MSCs in vitro (Discher et al., 2005, 
Karamichos et al., 2008, Vickers et al., 2010, Tse and Engler, 2011). Given that no significant differences 
were observed as a result of the incorporation of the two different GAG types, it is likely that any 
differences in MSC response observed during the in vitro culture were not strongly influenced by the 
mechanical properties of the scaffolds but were due to differences in composition and scaffold 
architecture.  
 
Although the presence of the different GAG types resulted in scaffolds with comparable mechanical 
properties, differences in cell response were observed between scaffolds containing different GAG types. 
After culture for 28 days in chondrogenic media with rMSCs, there was no difference in the cell density of 
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CCS and CHyA scaffolds (Fig. 4). However, CHyA scaffolds showed greater levels of cell infiltration than 
CCS scaffolds as shown by histological analysis (Fig. 5). In addition, CHyA scaffolds exhibited more 
homogeneous cell distribution than CCS scaffolds which were encapsulated by a layer of cells. This 
encapsulation on CCS scaffolds was observed as cells aggregating on the edge of scaffolds with limited 
cell infiltration towards the centre of scaffolds. There is growing evidence that the characteristic micro-
architecture of scaffolds plays a role in the migration of cells. A recent study showed that scaffolds with 
larger pore sizes (mean pore size range of 160-325 µm) resulted in greater levels of cell infiltration than 
scaffolds with smaller pore sizes (mean pore size range of 85-120 µm) (Murphy et al., 2010). In our study, 
it was evident that CCS scaffolds which possessed a mean pore size of 136 µm exhibited poor cell 
infiltration but surprisingly, CHyA scaffold with a smaller mean pore size of 93 µm exhibited greater levels 
of cell infiltration. This finding suggested that cell infiltration in CHyA scaffolds was governed by a 
mechanism distinct from pore size and architecture. Since the physical influence of the scaffold was 
minor, due to the similar mechanical properties of CCS and CHYA scaffolds, chemical properties of HyA, 
within the scaffold over the 28 days may also play a major role in this behaviour. The high anionic charge 
of HyA may alter the visco-elastic properties of the pericellular matrix surrounding cells and as a result, 
preventing cells from adhering firmly onto scaffolds struts possibly leading to increased migration (Toole, 
2001, Chen and Abatangelo, 1999). Another mechanism by which cell migration could be occurring may 
be a result of intracellular signalling pathways initiated by the specific interaction of MSCs and HyA 
through cell receptors such as integrins, CD44 and RHAMM (Receptor for Hyaluronic Acid Mediated 
Motility) (Toole, 2001, Chen and Abatangelo, 1999, Friedl and Bröcker, 2000, Knudson, 2003). Indeed it 
has been shown that inhibition of CD44 receptor resulted in MSCs with a reduced motility on HyA coated 
surfaces (Zhu et al. 2006). Therefore, there is a possibility that one of the stimuli for the greater levels of 
cell infiltration on CHyA scaffolds may be mediated by the interaction of MSCs and HyA. 
 
While the presence of TGF-β resulted in MSC differentiation down a chondrogenic lineage in all scaffold 
groups, the level of gene expression was seen to be largely influenced by the composition of the 
scaffolds. The presence of HyA markedly affected the level of early-stage chondrogenic gene expression 
within the scaffolds at a number of culture time points (Fig. 6). In particular, SOX-9 and collagen type II 
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genes were found to be highly expressed on the CHyA group (60-fold and 35-fold increase respectively) 
relative to CCS scaffolds at day 14. Previous studies investigating MSC differentiation down a 
chondrocytic lineage within porous scaffolds in the presence of TGF-β have been shown to induce MSC 
differentiation down a chondrogenic lineage (Jenner et al., 2007, Li et al., 2005, Chung and Burdick, 
2008). In particular, a number of studies have shown that at 14 days, MSC differentiation and subsequent 
collagen type II gene expression was evident in the presence of TGF-β (Lee et al., 2008, Lisignoli et al., 
2005, Bosnakovski et al., 2006, Park et al., 2009). Pellet culture systems are believed to be ideal culture 
environments to induce chondrogenesis due to the cell-cell contact which mimics the high cell density of 
embryonic cartilage development and maintains a chondrocytic phenotype (Fan et al., 2008, Chang et al., 
2008, Zhang et al., 2010). A study comparing pellet culture and 3-dimensional culture showed that there 
was a significant increase in collagen type II expression on pellet cultures than on alginate and chitosan 
beads at day 14 (Bernstein et al., 2009). However, our results demonstrated that the use of CHyA 
scaffolds, with a relatively low cell density, exhibited chondrocyte-specific gene expression with high 
levels of SOX-9 and collagen type II as early as 14 days. Due to the highly porous nature of the scaffolds 
used in this study, we believe that the cell density was sufficient to investigate the interaction of cells and 
scaffolds. This cell seeding density was based on previous work carried out in our laboratory and has 
been used both in vitro and in vivo (Farrell et al., 2006, Byrne et al., 2008, Lyons et al., 2010b, Alhag et 
al., 2011). A higher cell density would create a phenomenon whereby cell-cell interaction out-weighed 
cell-matrix interaction resulting in an imprecise interpretation of the response of MSCs to the differing 
compositions. The exact mechanism as to how HyA mediated earlier expression of collagen type II than 
CS is not fully understood. Nevertheless, we would suggest that the presence of HyA on the pericellular 
matrix of cells may facilitate the association of soluble growth factors available through immobilisation. 
Thus, HyA may provide co-receptors for sequestration and presentation of the necessary biochemical 
factors for commitment towards a chondrocytic lineage leading to gene expression and protein synthesis. 
 
Consistent with the gene expression results, cartilage matrix production occurred earlier in the presence 
of HyA relative to GAG-free and CCS scaffolds. By day 14, significantly higher levels of sGAG production 
in CHyA scaffolds in comparison to GAG-free and CCS scaffolds were observed (Fig. 7). GAG-free 
18 
 
collagen and CCS scaffolds exhibited low sGAG accumulation by day 14 and it was only by day 28 that 
the total sGAG content was significantly increased and comparable to CHyA scaffolds. While the 
quantities of sGAG were comparable between CCS and CHyA scaffolds at day 28, it was only after 
comparing sGAG production with histological analysis that the advantage of CHyA was realised. It was 
evident that sGAG content was more evenly distributed in the CHyA scaffolds than the GAG-free collagen 
scaffolds and CCS scaffolds. Absence of HyA resulted in accumulation of sGAG on the periphery of 
scaffolds. CS is the main type of GAG in cartilage ECM and has been shown to be chondro-inductive in 
vitro (van Susante et al., 2001). From our results, it was evident that the presence of CS led to MSC 
differentiation and chondrogenesis. However, the restricted cell and matrix distribution on CCS scaffolds 
may have inhibited early retention of sGAG content within the scaffold and may explain the low sGAG 
content at day 14. HyA is secreted prior to condensation during cartilage growth and is quickly followed 
by formation of aggregates of proteoglycans held together by the HyA molecule (Toole, 2001, Knudson 
and Knudson, 2004). Due to the proteoglycan-binding role of HyA in the native cartilage ECM, we 
hypothesise that the presence of HyA in a scaffold may aid in the aggregation of synthesised sGAG 
within the scaffold and thus may explain the better distribution and higher level as early as day 14.  
 
As matrix deposition commences, it is believed that there is a switch to expression of late stage genes 
such as aggrecan (Goldring et al., 2006). Therefore we believe that the decrease in SOX9 and collagen 
type II from 14 to 28 days in CHyA scaffolds may indicate that cells are maturing and initiating expression 
of later stage markers of chondrogenesis. A similar trend was observed in sGAG content whereby 
production was higher in CHyA scaffolds at day 14 in comparison to CCS and GAG-free scaffolds but the 
rate of production decreased beyond day 14. At day 28 CHyA scaffolds may have been saturated with the 
synthesised sGAG owing to the slowed rate of production between 14 and 28 days. It is not certain 
whether other scaffolds would show a similar decline at later time points based on our results. However, 
this down regulation may simply point to a faster rate of differentiation and maturation in the presence of 
HyA in comparison to CS. 
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The CG scaffolds in this study showed an increase in compressive modulus from 0.6 kPa to 
approximately 1.6 kPa after 28 days in culture due to matrix deposition. For comparison, native bovine 
articular cartilage has a compressive modulus of approximately 300 kPa (Pfeiffer et al., 2008). This is 
mainly due to the complex organisation of collagen, proteoglycans and water in native articular cartilage. 
We are not attempting to engineer tissue in vitro that is comparable to native articular tissue as we would 
expect that if these constructs were implanted in vivo, they would be remodeled and replaced with new 
tissue and that the most important mechanical properties are that of the regenerated tissue. However, we 
observe an increase in bulk compressive modulus of the scaffolds (by approximately 1 kPa) as the cells 
synthesise new matrix after only 28 days in culture. In addition, the ability of MSCs to differentiate to a 
chondrocyte-specific phenotype and synthesise matrix increasing the overall modulus of the scaffolds 
demonstrates both the effectiveness of using MSCs as an alternative to chondrocytes for in vitro 
investigation and the potential of these scaffolds for cartilage repair. 
 
5. Conclusion 
In this study, we have shown that the composition of scaffolds for tissue engineering plays a major role in 
the behaviour of MSCs. With the addition of GAGs, the biofunctionality of collagen-based scaffolds for 
chondrogenesis was significantly enhanced. Furthermore, we speculate that HyA may stimulate migration 
of MSCs into scaffolds by a mechanism distinct from micro-architecture, conceivably through a 
chemotaxic or perhaps through the high anionic charge of HyA in altering the interaction of cells and 
matrices. These CHyA scaffolds demonstrated the ability to facilitate MSC differentiation down a 
chondrogenic lineage and promote cartilage-specific matrix production in vitro. The quality of cartilage 
matrix produced within CHyA scaffolds, as assessed by collagen type II gene expression, was superior to 
that of CCS or GAG-free collagen scaffolds as early as 14 days. These findings make CHyA an excellent 
scaffold for further investigation of cartilage defect repair. 
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Table and figure legends 
Table 1. Effect of GAG type on mean scaffold pore size and percentage porosity. Mean pore size was 
measured as an average diameter (µm) of scaffold pores. Percentage porosity was calculated as a 
relative ratio of scaffold density to the density of CG. The presence of CS significantly increased the 
mean pore size of collagen scaffolds whereas HyA significantly decreased the mean pore size. Values 
are expressed as mean + standard deviation, n=6. (*) denotes p<0.04 statistical significant difference in 
comparison to collagen. 
 
Figure 1 Representative SEM images of a CG scaffold showing the pore interconnectivity. The images 
were taken at 15 kV and a magnification of x10 (A) and x100 (B). The scale bars represent 1mm (A) and 
100 μm (B). 
 
Figure 2. FTIR spectroscopy of collagen and CG scaffolds cross-linked using DHT treatment showing 
characteristic features of collagen and GAG. Amide bands were found to be present in the scaffold 
structure of all scaffold variants after DHT treatment. Ester bands which correspond to the presence of 
GAGs were also found to be present on the structure of CCS and CHyA scaffolds after cross-linking. 
 
Figure 3. The compressive modulus of collagen and CG scaffolds in kPa. Unconfined uni-axial testing 
was carried out on uncrosslinked and DHT-treated (105ºC for 24 hours) scaffolds. The graph shows an 
increase in compressive modulus due to DHT treatment. Values are expressed as mean + standard 
deviation, n=3. * denotes p<0.05 statistical significant difference in comparison to uncrosslinked scaffolds. 
 
Figure 4. Cell density of collagen and CG scaffolds after 14 and 28 days in culture with rMSCs in 
chondrogenic medium. Cell density was analysed by Hoechst dye DNA quantification. GAG-free collagen 
scaffolds appear to have significantly lower cell density than CCS and CHyA scaffolds after 14 days. 
Values are expressed as mean + standard deviation, n=3. * denotes p<0.05 statistical significant 
difference in comparison to collagen at day 14. 
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Figure 5. Histological sections of collagen (A), CCS (B) and CHyA (C) scaffolds after 28 days in culture 
with rMSCs in chondrogenic medium. The sections were stained with haematoxylin (red) which stains 
cellular nuclei, safranin-O (pink) which stains synthesised sulphated GAG, and fast green a light counter 
stain. Scale bar represents 200 µm length. CHyA scaffolds have a homogeneous cell distribution and 
more positive staining for synthesised sGAG. GAG-free collagen scaffolds and CCS scaffolds 
demonstrate an encapsulation of cells and synthesised sGAG 
 
Figure 6. Gene expression of SOX-9 (A); collagen type I (B); collagen type II (C); and collagen type X 
(D), assessed after day 14 and 28 in culture with rMSCs in chondrogenic medium. The expression was 
normalised to a housekeeping gene GAPDH. The values are expressed as fold difference in comparison 
to expression by cells in collagen scaffolds at day 0. a denotes p<0.01 statistical significant difference in 
comparison to collagen at day 14, b denotes p<0.01 statistical significant difference in comparison to 
CHyA at day 14, c denotes p<0.01 statistical significant difference in comparison to CHyA at day 28. Early 
up-regulation of SOX-9 and collagen type II observed on CHyA scaffolds in comparison to GAG-free 
collagen and CCS scaffolds at day 14.  
 
Figure 7. The total content of synthesised sulphated GAG (sGAG) in scaffolds assessed after 14 and 28 
days in culture using a DMMB assay, normalised to DNA content. Graph shows mean + standard 
deviation, n=3 (b denotes p<0.01 statistical significant difference in comparison to CHyA at day 14). The 
graph shows significant increase in sGAG content on the CHyA scaffold in comparison to GAG-free and 
CCS scaffolds as early as day 14. 
 
Figure 8. The bulk compressive modulus of rMSC-seeded scaffolds cultured up to 28 days with 
chondrogenic medium. The graph shows an increase in compressive modulus with time in culture from 
day 0. CCS and CHyA scaffolds possessed significantly higher compressive modulus than GAG-free 
collagen scaffolds after 28 days in culture. Values are expressed as mean + standard deviation, n=3. * 
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denotes p<0.05 statistical significant difference in comparison to collagen at day 28. # denotes p<0.05 
statistical significant difference in comparison to day 14. 
 
 
Table 1.  
Scaffold type   Mean pore size (µm)  Porosity (%) 
Collagen   103.15 + 11.17   99.49 + 0.014 
CCS   136.17 + 18.98 
(
*
)   
99.51 + 0.023 
CHyA   93.88 + 8.78    98.79 + 0.017 
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